Differential expression of Ki-67 and sex steroid hormone receptors between genders in peritoneal mesothelioma

Pathology and Oncology Research

Volumn 15, Issue 4, 2009, Pages 671-678

  Chua, Terence C ^a   Yao, Peng ^a   Akther, Javed ^a   Young, Lawrence ^a   Bao, Shisan ^b   Samaraweera, Ushma ^c   Yan, Tristan D ^a   Morris, David L ^a  

^a ST GEORGE HOSPITAL   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

^c PRINCE OF WALES HOSPITAL   (Australia)

Author keywords

Androgen receptor; Cytoreductive surgery; Estrogen receptor; Ki 67 antigen; Mesothelioma; Progesterone receptor

Indexed keywords

ANDROGEN RECEPTOR; ESTROGEN RECEPTOR; KI 67 ANTIGEN; PROGESTERONE RECEPTOR;

ADULT; ARTICLE; CANCER SURGERY; CLINICAL ARTICLE; CYTOREDUCTIVE SURGERY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; PERITONEUM MESOTHELIOMA; PROTEIN EXPRESSION; SEX DIFFERENCE;

ADULT; AGED; CELL PROLIFERATION; FEMALE; HUMANS; KAPLAN-MEIERS ESTIMATE; KI-67 ANTIGEN; MALE; MESOTHELIOMA; MIDDLE AGED; PERITONEAL NEOPLASMS; RECEPTORS, ANDROGEN; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE; SEX CHARACTERISTICS; SURVIVAL ANALYSIS;

EID: 75049085762     PISSN: 12194956     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12253-009-9170-0     Document Type: Article

References (39)

1. P Boffetta 2007 Epidemiology of peritoneal mesothelioma: a review Ann. Oncol. 18 985 90 10.1093/annonc/mdl345 1:STN:280:DC%2BD2szmvFOktQ%3D%3D 17030547 (Pubitemid 47050488)
2. BW Robinson RA Lake 2005 Advances in malignant mesothelioma N Engl J Med. 353 1591 603 10.1056/NEJMra050152 1:CAS:528:DC%2BD2MXhtFWhur7O 16221782 (Pubitemid 41434638)
3. PH Sugarbaker LS Welch F Mohamed OA Glehen 2003 Review of peritoneal mesothelioma at theWashington Cancer Institute Surg Oncol Clin N Am. 12 605 621 10.1016/S1055-3207(03)00045-0 14567020 (Pubitemid 36920088)
4. YI Acherman LS Welch CM Bromley PH Sugarbaker 2003 Clinical presentation of peritoneal mesothelioma Tumori 89 3 269 73 12908781
5. B Castagneto M Botta E Aitini F Spigno D Degiovanni O Alabiso, et al. 2008 Phase II study of pemetrexed in combination with carboplatin in patients with malignant pleural mesothelioma (MPM) Ann. Oncol. 19 2 370 3 10.1093/annonc/mdm501 1:STN:280:DC%2BD1c%2FosVChug%3D%3D 18156144 (Pubitemid 351201722)
6. NJ Vogelzang JJ Rusthoven J Symanowski C Denham E Kaukel P Ruffie, et al. 2003 Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma J Clin Oncol 21 14 2636 44 10.1200/JCO.2003.11.136 1:CAS:528:DC%2BD2cXptlCktL4%3D 12860938 (Pubitemid 46606305)
7. PA Janne AJ Wozniak CP Belani M-L Keohan HJ Ross JA Polikoff, et al. 2005 Open-label study of pemetrexed alone or in combination with cisplatin for the treatment of patients with peritoneal mesothelioma: outcomes of an expanded access program Clin Lung Cancer 7 1 40 6 10.3816/CLC.2005.n.020 1:CAS:528:DC%2BD2MXpslOqsbY%3D 16098243
8. TD Yan L Welch D Black PH Sugarbaker 2007 A systematic review on the efficacy of cytoreductive surgery combined with perioperative intraperitoneal chemotherapy for diffuse malignancy peritoneal mesothelioma Ann. Oncol. 18 5 827 34 10.1093/annonc/mdl428 1:STN:280:DC%2BD2s3ns1eqsg%3D%3D 17130182 (Pubitemid 47054078)
9. L Johansson CJ Linden 1996 Aspects of histopathologic subtype as a prognostic factor in 85 pleural mesotheliomas Chest 109 1 109 14 10.1378/chest.109.1.109 1:STN:280:DyaK287jt1altA%3D%3D 8549169
10. TC Mineo V Ambrogi E Pompeo A Baldi F Stella P Aurea, et al. 2008 The value of occult disease in resection margin and lymph node after extrapleural pneumonectomy for malignant mesothelioma Ann Thorac Surg 85 5 1740 6 10.1016/j.athoracsur.2008.01.088 18442576 (Pubitemid 351608195)
11. JG Edwards DJ Stewart A Martin-Ucar S Muller C Richards DA Waller 2006 The pattern of lymph node involvement influences outcome after extrapleural pneumonectomy for malignant mesothelioma J Thorac Cardiovasc Surg 131 5 981 7 10.1016/j.jtcvs.2005.11.044 16678579
12. TD Yan D Yoo PH Sugarbaker 2006 Significance of lymph node metastasis in patients with diffuse malignant peritoneal mesothelioma Eur. J. Surg. Oncol. 32 9 948 53 10.1016/j.ejso.2006.05.009 1:STN:280:DC%2BD28njvVGmsw%3D%3D 16806796 (Pubitemid 44615587)
13. D Curran T Sahmoud P Therasse J van Meerbeeck PE Postmus G Giaccone 1998 Prognostic factors in patients with pleural mesothelioma: the European Organization for Research and Treatment of Cancer experience J Clin Oncol 16 1 145 52 1:STN:280:DyaK1c7gtFKrtA%3D%3D 9440736
14. VI Adams KK Unni JR Muhm JR Jett DM Ilstrup PE Bernatz 1986 Diffuse malignant mesothelioma of pleura. Diagnosis and survival in 92 cases Cancer 58 7 1540 51 10.1002/1097-0142(19861001)58:7<1540::AID-CNCR2820580727>3.0. CO;2-5 1:STN:280:DyaL283pvVWhsw%3D%3D 3742473
15. M Metintas S Metintas I Ucgun AR Gibbs E Harmanci F Alatas, et al. 2001 Prognostic factors in diffuse malignant pleural mesothelioma: effects of pretreatment clinical and laboratory characteristics Respir. Med. 95 10 829 35 10.1053/rmed.2001.1178 1:STN:280:DC%2BD3MrlsFaquw%3D%3D 11601750 (Pubitemid 33019580)
16. TD Yan E Popa EA Brun CA Cerruto PH Sugarbaker 2006 Sex difference in diffuse malignant peritoneal mesothelioma Br. J. Surg. 93 12 1536 42 10.1002/bjs.5377 1:STN:280:DC%2BD28noslOkuw%3D%3D 17048277 (Pubitemid 44893657)
17. KH Antman RH Blum JS Greenberger G Flowerdew AT Skarin GP Canellos 1980 Multimodality therapy for malignant mesothelioma based on a study of natural history Am. J. Med. 68 3 356 62 10.1016/0002-9343(80)90103-5 1:STN:280:DyaL3c7ltV2htg%3D%3D 7361805
18. RM Flores HI Pass VE Seshan J Dycoco M Zakowski M Carbone, et al. 2008 Extrapleural pneumonectomy versus pleurectomy/decortication in the surgical management of malignant pleural mesothelioma: results in 663 patients Journal of Thoracic & Cardiovascular Surgery 135 3 620 6 10.1016/j.jtcvs.2007.10.054
19. V Neumann A Rutten M Scharmach KM Muller M Fischer 2004 Factors influencing long-term survival in mesothelioma patients-results of the German mesothelioma register International Archives of Occupational & Environmental Health 77 3 191 9 10.1007/s00420-003-0498-6 1:STN:280:DC%2BD2c7kvVKlug%3D%3D (Pubitemid 38678976)
20. VW Rusch ES Venkatraman 1999 Important prognostic factors in patients with malignant pleural mesothelioma, managed surgically Ann. Thorac. Surg. 68 5 1799 804 10.1016/S0003-4975(99)01038-3 1:STN:280:DC%2BD3c%2FkvFOmtA%3D%3D 10585061
21. MA Carson-Jurica WT Schrader BW O'Malley 1990 Steroid receptor family: structure and functions Endocr. Rev. 11 201 20 10.1210/edrv-11-2-201 1:CAS:528:DyaK3cXksFalsrw%3D 2194782
22. NJ McKenna RB Lanz BW O'Malley 1999 Nuclear receptor coregulators: cellular and molecular biology Endocr. Rev. 20 321 44 10.1210/er.20.3.321 1:CAS:528:DyaK1MXktVaqtLs%3D 10368774
23. PH Sugarbaker 1995 Peritonectomy procedures Ann. Surg. 221 29 42 1:STN:280:DyaK2M7is1OhsQ%3D%3D 7826158
24. R Garcia-Carbonero L Paz-Ares 2006 Systemic chemotherapy in the management of malignant peritoneal mesothelioma Eur. J. Surg. Oncol. 32 6 676 81 10.1016/j.ejso.2006.03.009 1:STN:280:DC%2BD28vjs12lug%3D%3D 16616827 (Pubitemid 44063996)
25. JG Thomas Scholzen 2000 The Ki-67 protein: From the known and the unknown J Cell Physiol 182 3 311 22 10.1002/(SICI)1097-4652(200003)182:3<311::AID- JCP1>3.0.CO;2-9 (Pubitemid 30054364)
26. J Smolle R Hoffmann-Wellenhof H-P Soyer H Stettner H Kerl 1989 Nuclear Size and Shape Parameters Correlate with Proliferative Activity in Cutaneous Melanocytic Tumors J Invest Dermatol 93 1 178 82 10.1111/1523-1747.ep12277396 1:STN:280:DyaL1MzgvFyktg%3D%3D 2746003
27. X Gao BW Loggie Z Nawaz 2002 The roles of sex steroid receptor coregulators in cancer Molecular Cancer. 1 7 10.1186/1476-4598-1-7 12473178 (Pubitemid 38751449)
28. Schiff R, Saw F (2002) The importance of the estrogen receptor in breast cancer. In: Pasqualini JR (ed) Breast cancer: prognosis, treatment, and prevention. Marcel Dekker, New York, NY, pp 149-86
29. BG Rowan BW O'Malley 2000 Progesterone receptor coactivators Steroids 65 10-11 545 9 10.1016/S0039-128X(00)00112-4 1:CAS:528:DC%2BD3cXosFCju78%3D 11108858
30. HV Heemers DJ Tindall 2007 Androgen receptor (AR) coregulators: a diversity of functions converging on and regulating the AR transcriptional complex Endocr. Rev. 28 7 778 808 10.1210/er.2007-0019 1:CAS:528: DC%2BD1cXhtVKlsrk%3D 17940184 (Pubitemid 350294296)
31. PD Ryan PE Goss 2008 The emerging role of the insulin-like growth factor pathway as a therapeutic target in cancer Oncologist 13 1 16 24 10.1634/theoncologist.2007-0199 1:CAS:528:DC%2BD1cXivFGrt78%3D 18245009 (Pubitemid 351206693)
32. RJ Barnetson RA Burnett I Downie CM Harper F Roberts 2006 Immunohistochemical analysis of peritoneal mesothelioma and primary and secondary serous carcinoma of the peritoneum: antibodies to estrogen and progesterone receptors are useful Am. J. Clin. Pathol. 125 1 67 76 1:CAS:528:DC%2BD28Xpt1CksQ%3D%3D 16482993
33. K Horita N Inase S Miyake B Formby H Toyoda Y Yoshizawa 2001 Progesterone induces apoptosis in malignant mesothelioma cells Anticancer Res. 21 6A 3871 4 1:CAS:528:DC%2BD38Xis1artr4%3D 11911261
34. RN Sawh A Malpica MT Deavers J Liu EG Silva 2003 Benign cystic mesothelioma of the peritoneum: a clinicopathologic study of 17 cases and immunohistochemical analysis of estrogen and progesterone receptor status Hum. Pathol. 34 4 369 74 10.1053/hupa.2003.31 1:CAS:528:DC%2BD3sXjs1equrs%3D 12733118 (Pubitemid 36535021)
35. B Fisher J Costantino C Redmond R Poisson D Bowman J Couture, et al. 1989 A randomized clinical trial evaluating tamoxifen in the treatment of patients with node-negative breast cancer who have estrogen-receptor-positive tumors N Engl J Med 320 8 479 84 1:STN:280:DyaL1M7islChsw%3D%3D 2644532
36. Elledge RM, Allred DC (2004) Clinical aspects of estrogen and progesterone receptors. In: Harris JR, Lippman ME, Morrow M (eds) Diseases of the Breast, 3rd edn. Lippincott Williams and Wilkins, Philadelphia, PA, pp 603-17
37. X Cui R Schiff G Arpino CK Osborne AV Lee 2005 Biology of progesterone receptor loss in breast cancer and its implications for endocrine therapy J Clin Oncol 23 30 7721 35 10.1200/JCO.2005.09.004 1:CAS:528:DC%2BD2MXht1WrsrrM 16234531 (Pubitemid 46291836)
38. CL Smith BW O'Malley 2004 Coregulator Function: A Key to Understanding Tissue Specificity of Selective Receptor Modulators Endocr. Rev. 25 1 45 71 10.1210/er.2003-0023 1:CAS:528:DC%2BD2cXhvFOmt74%3D 14769827 (Pubitemid 38292038)
39. FCH d'Ancona FMJ Debruyne 2005 Endocrine approaches in the therapy of prostate carcinoma Hum Reprod Update 11 3 309 17 10.1093/humupd/dmi004 15790600 (Pubitemid 40668113)